Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease

被引：0
|
作者：
Patriarca, F
Sperotto, A
Prosdocimo, S
Damiani, D
Morreale, G
Olivieri, A
Bonifazi, F
Milone, G
Peccatori, J
Corradini, P
Fanin, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [21] Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
    Malard, Florent
    Huang, Xiao-Jun
    Sim, Joycelyn P. Y.
    LEUKEMIA, 2020, 34 (05) : 1229 - 1240
  • [22] Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease
    Bordigoni, Pierre
    Dimicoli, Sophie
    Clement, Laurence
    Baumann, Cedric
    Salmon, Alexandra
    Witz, Francis
    Feugier, Pierre
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (03) : 382 - 385
  • [23] Plasma adiponectin levels in patients with infliximab treatment for steroid-refractory gastrointestinal acute graft-versus-host disease
    Murayama, Yoko
    Tsutsui, Shusaku
    Shinomura, Yasuhisa
    Hayashi, Norio
    GASTROENTEROLOGY, 2008, 134 (04) : A215 - A215
  • [24] Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
    Alex Ganetsky
    Noelle V. Frey
    Elizabeth O. Hexner
    Alison W. Loren
    Saar I. Gill
    Selina M. Luger
    James K. Mangan
    Mary Ellen Martin
    Daria V. Babushok
    William R. Drobyski
    Jacqueline Smith
    Colleen Timlin
    Craig W. Freyer
    Edward A. Stadtmauer
    David L. Porter
    Bone Marrow Transplantation, 2019, 54 : 212 - 217
  • [25] Low dose alemtuzumab is effective in the treatment of severe steroid-refractory acute graft-versus-host disease
    Repp, R
    Claviez, A
    Gahn, B
    Schub, N
    Beck, C
    Helm, F
    Gramatzki, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S97 - S97
  • [26] Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
    Ganetsky, Alex
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Gill, Saar I.
    Luger, Selina M.
    Mangan, James K.
    Martin, Mary Ellen
    Babushok, Daria V.
    Drobyski, William R.
    Smith, Jacqueline
    Timlin, Colleen
    Freyer, Craig W.
    Stadtmauer, Edward A.
    Porter, David L.
    BONE MARROW TRANSPLANTATION, 2019, 54 (02) : 212 - 217
  • [27] Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease
    Jerkins, James H.
    Hamadani, Mehdi
    Zook, Felicia
    Epperla, Narendranath
    Shaw, Bronwen E.
    Saber, Wael
    Rizzo, J. Douglas
    Pasquini, Marcelo
    Chhabra, Saurabh
    Drobyski, William R.
    Hari, Parameswaran N.
    Shah, Nirav N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : E610 - E611
  • [28] Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease:: a pilot study
    Greinix, HT
    Volc-Platzer, B
    Kalhs, P
    Fischer, G
    Rosenmayr, A
    Keil, F
    Hönigsmann, H
    Knobler, RM
    BLOOD, 2000, 96 (07) : 2426 - 2431
  • [29] Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease
    Radojcic, Vedran
    Pletneva, Maria
    Lee, Catherine J.
    Ivcevic, Sanja
    Sarantopoulos, Stefanie
    Couriel, Daniel
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (02) : E120 - E122
  • [30] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
12345